Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with acute episode (first or relapse), or upon revisit and identified not achieving remission of schizophrenia or schizoaffective disorder (according to remission criteria of schizophrenia)
Male or female aged between 18 and 65 years
Patients recruited from both in-patient and out-patient clinics
Patients who are cooperative, by judgment from investigators, and the use of oral antipsychotic considered adequate
You may not be if
Pregnancy or lactation
Patients who, in the opinion of the investigator, pose an imminent risk of suicide or a danger to self or others
Known intolerance, lack of response, or contraindication to prescribed atypical antipsychotic, as judged by the investigator
Administration of a depot antipsychotic injection within one dosing interval (for the depot) before enrolment and patients prescribed with clozapine within 3 months prior to enrolment
